Glucomodicum

Discovery of a new,
enabling technology

GlucoModicum has discovered and developed a new technology which enables needle-free health monitoring. This technology has never been reported earlier and, during the past four years, we have developed it into a consumer product. We have a portfolio of products and solutions of which the accuracy and safety of the technology has been validated in clinical pilots.

The first solution has been created for needle-free glucose monitoring.

News

09.09.2020

Enhanced and miniaturized electronics & functionality for the industrial product (“Flint 2”) has been completed

10.07.2020

GlucoModicum core patent has been granted in 18 new countries in EU and Asia

08.07.2020

GlucoModicum has completed one of the key milestones, M1, in reaching the CE mark for the first in-market product (“Flint 2”)

10.06.2020

GlucoModicum has received a Seal of Excellence from the European Commission

All news

Wrist Watch

Continuous Glucose Monitoring (CGM)

Small size
Affordable

Simple and easy to use

Feels comfortable on your wrist

Connected device

Simple and easy to use

Feels comfortable on your wrist

Connected device

Different form factors

The technology can be miniaturized into smaller-sized form factors such as a ring and a patch. The work and patent portfolio are on-going in order to complete the first prototypes.

Ring

Adhesive patch Patch

Solutions

All GlucoModicum products are connected devices. Data and insights are continuously synced with smart phone and can be uploaded to cloud.

Diabetes

Track your glucose levels as needed.

1/3 of the world population is at risk for developing diabetes. If you believe that you are at risk, you can periodically check your glucose levels.
Globally, +400 million people have diabetes while more than 100 million people don’t yet know that they have diabetes. This requires either continuous glucose monitoring or periodic measurements throughout the day.